Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 6,395 | 6,669 | 4,629 | 4,692 | 0 |
| Operating Income | -6,395 | -6,669 | -4,629 | -4,692 | N/A |
| Pre-tax Income | -6,395 | -6,669 | -4,629 | -4,692 | 0 |
| Income Tax | 264 | 144 | 144 | 144 | N/A |
| Net Income Continuous | -6,659 | -6,813 | -4,773 | -4,836 | N/A |
| Net Income | $-6,659 | $-6,813 | $-4,773 | $-4,836 | $N/A |
| EPS Basic Total Ops | -0.09 | -0.10 | -0.07 | -0.07 | N/A |
| EPS Basic Continuous Ops | -0.09 | -0.10 | -0.07 | -0.07 | N/A |
| EPS Diluted Total Ops | -0.09 | -0.10 | -0.07 | -0.07 | N/A |
| EPS Diluted Continuous Ops | -0.09 | -0.10 | -0.07 | -0.07 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.09 | N/A | 0.04 | N/A | N/A |
| EBITDA(a) | $-6,395 | $-6,669 | $-4,629 | $-4,692 | $N/A |